SOUTH
SAN FRANCISCO, California and VANCOUVER,
Canada, Feb. 6, 2024
/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:
EPIX), a clinical-stage pharmaceutical company focused on
developing novel therapies for the treatment of prostate cancer,
today announced that the Company will be participating in a
virtual fireside chat at the Oppenheimer 34th Annual
Healthcare Life Sciences Conference on Tuesday, February 13,
2024, at 12:40 p.m. ET.
David. R. Parkinson, President, and Chief Executive
Officer; Peter Virsik, Chief Operating Officer; and David
S. Wood, Chief Financial Officer, will host and participate in
one-on-one meetings.
A live webcast of the fireside chat can be accessed in the
Investors/Events & Presentations section of ESSA's website
at www.essapharma.com. Following the event, the webcast will
be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please
visit www.essapharma.com, and follow us
on Twitter and LinkedIn.
Contacts
ESSA Pharma, Inc.
Peter Virsik, Chief Operating
Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302054080.html
SOURCE ESSA Pharma Inc